Loading company
AC Immune SA
ACIU · Nasdaq · ·
Next earnings: November 3, 2026
$2.59-1.1%Sep 29 close
- 1M
- -2.3%
- 6M
- +1.2%
- 1Y
- -10.4%
- 5Y
- -63.7%
ACIU · Nasdaq · ·
Next earnings: November 3, 2026
$2.59-1.1%Sep 29 close
AC Immune SA is scheduled to report next on November 3, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
The quarter ending March 31, 2026, against the same quarter a year earlier.
| Measure | 3 months toMar 31, 2026 | 3 months toSep 30, 2024 | Change |
|---|---|---|---|
| Total Revenue | $1.3M | $30.6M | -95.61% |
| Profit | -$19M | -$27.3M | +30.33% |
| Profit per share | -$0.25 | -$0.19 | -31.25% |
| Free Cash Flow | -$16.3M | -$28.4M | +42.66% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Risk” in the Annual Report on Form 20-F. Critical judgments and accounting estimates There have been no material changes to the material accounting policies and estimates described under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Judgments and Accounting Estimates” in the Annual Report on Form 20-F. 12
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from the 6-K AC Immune SA filed on August 5, 2026 with its results; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
AC Immune SA has no earnings call transcript available.